These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23059959)

  • 1. Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients.
    Chen IC; Hsu C; Chen YC; Chien SF; Kao HF; Chang SY; Hu FC; Yeh KH
    Ann Oncol; 2013 Feb; 24(2):463-468. PubMed ID: 23059959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers.
    Kao HF; Chen IC; Hsu C; Chang SY; Chien SF; Chen YC; Hu FC; Yang JC; Cheng AL; Yeh KH
    Support Care Cancer; 2014 May; 22(5):1189-97. PubMed ID: 24384684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units.
    Alonso-Echanove J; Edwards JR; Richards MJ; Brennan P; Venezia RA; Keen J; Ashline V; Kirkland K; Chou E; Hupert M; Veeder AV; Speas J; Kaye J; Sharma K; Martin A; Moroz VD; Gaynes RP
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):916-25. PubMed ID: 14700407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of infectious complications of the implantable venous access system in a general oncologic population.
    Chang L; Tsai JS; Huang SJ; Shih CC
    Am J Infect Control; 2003 Feb; 31(1):34-9. PubMed ID: 12548255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate duration of peripherally inserted central catheter maintenance to prevent central line-associated bloodstream infection.
    Park S; Moon S; Pai H; Kim B
    PLoS One; 2020; 15(6):e0234966. PubMed ID: 32569313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Totally implantable central venous access port infections in patients with digestive cancer: incidence and risk factors.
    Touré A; Vanhems P; Lombard-Bohas C; Cassier P; Péré-Vergé D; Souquet JC; Ecochard R; Chambrier C
    Am J Infect Control; 2012 Dec; 40(10):935-9. PubMed ID: 22633131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Profile of Microorganisms Responsible for Port-Related Bacteremia in Pediatric Hemato-Oncological Patients.
    Gowin E; Świątek-Kościelna B; Mańkowski P; Januszkiewicz-Lewandowska D
    Cancer Control; 2020; 27(1):1073274820904696. PubMed ID: 32157910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Exposition to total parenteral nutrition increases the risk of catheter-related bloodstream infection].
    Vergara T; Véliz E; Fica A
    Rev Chilena Infectol; 2016 Dec; 33(6):603-608. PubMed ID: 28146184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman.
    D'Souza PC; Kumar S; Kakaria A; Al-Sukaiti R; Al-Baimani K; Hamid RS; Mittal AK; Al-Balushi M; Burney IA; Al-Moundhri MS
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e103-e109. PubMed ID: 33777430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.
    Wildgruber M; Lueg C; Borgmeyer S; Karimov I; Braun U; Kiechle M; Meier R; Koehler M; Ettl J; Berger H
    Eur J Cancer; 2016 May; 59():113-124. PubMed ID: 27023050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.
    Maki DG; Kluger DM; Crnich CJ
    Mayo Clin Proc; 2006 Sep; 81(9):1159-71. PubMed ID: 16970212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total parenteral nutrition is a major risk factor for central venous catheter-related bloodstream infection in colorectal cancer patients receiving postoperative chemotherapy.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Eur Surg Res; 2008; 41(4):341-5. PubMed ID: 18841020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is diabetes a risk factor for central venous access port-related bloodstream infection in oncological patients?
    Touré A; Vanhems P; Lombard-Bohas C; Souquet JC; Lauverjat M; Chambrier C
    Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):133-8. PubMed ID: 22930406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of understaffing in central venous catheter-associated bloodstream infections.
    Fridkin SK; Pear SM; Williamson TH; Galgiani JN; Jarvis WR
    Infect Control Hosp Epidemiol; 1996 Mar; 17(3):150-8. PubMed ID: 8708352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumors: a single institution-based study.
    Ohno H; Mizumoto C; Otsuki Y; Oguma S; Yoshida Y
    Int J Clin Oncol; 2010 Apr; 15(2):172-8. PubMed ID: 20195680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a new guideline for central venous catheter care on sepsis in total parenteral nutrition: experience in Ramathibodi Hospital.
    Roongpisuthipong C; Getupook V; Chindavijak B
    J Med Assoc Thai; 2007 Oct; 90(10):2030-8. PubMed ID: 18041420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central venous catheter-related bloodstream infections: an analysis of incidence and risk factors in a cohort of 400 patients.
    Gowardman JR; Montgomery C; Thirlwell S; Shewan J; Idema A; Larsen PD; Havill JH
    Intensive Care Med; 1998 Oct; 24(10):1034-9. PubMed ID: 9840236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
    Schwarz RE; Groeger JS; Coit DG
    Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.
    Kakkos A; Bresson L; Hudry D; Cousin S; Lervat C; Bogart E; Meurant JP; El Bedoui S; Decanter G; Hannebicque K; Regis C; Hamdani A; Penel N; Tresch-Bruneel E; Narducci F
    Eur J Surg Oncol; 2017 Apr; 43(4):689-695. PubMed ID: 27889197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.